Fredun Pharmaceuticals share news, announcements and annual reports
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Fredun Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2016
Last close ₹1,408.20up ₹41.20 (3.01%)BSE ₹1,408.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,367.00.
2 Nov: open ₹1,360.00, high ₹1,420.00, low ₹1,350.10
52-week range of BSE trades to 2 Nov 2026
₹454.05Low, 12 Jan 2026₹1,666.35High, 8 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,380 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 58,78644.2% delivered
Fredun Pharmaceuticals board meetings
187 filed, newest first. Page 3 of 4.
Aug 2022
May 2022
9 May · Board meeting
Meeting on 16 May 2022: final dividend and audited results
Apr 2022
8 Apr · Board meeting
Meeting on 8 Apr 2022
Jan 2022
19 Jan · Board meeting
Meeting on 28 Jan 2022: quarterly results
Nov 2021
1 Nov · Board meeting
Meeting on 6 Nov 2021: quarterly results
Oct 2021
Sep 2021
20 Sep · Board meeting
Meeting on 22 Sep 2021
Aug 2021
5 Aug · Board meeting
Meeting on 10 Aug 2021: quarterly results
Jun 2021
21 Jun · Board meeting
Meeting on 28 Jun 2021: audited results
Feb 2021
Jan 2021
28 Jan · Board meeting
Meeting on 12 Feb 2021: quarterly results
Nov 2020
Oct 2020
26 Oct · Board meeting
Meeting on 9 Nov 2020: quarterly results
Sep 2020
4 Sep · Board meeting
Meeting on 15 Sep 2020: quarterly results
Jul 2020
27 Jul · Board meeting
Meeting on 29 Jul 2020: audited results
Feb 2020
Jan 2020
31 Jan · Board meeting
Meeting on 12 Feb 2020: quarterly results
Nov 2019
1 Nov · Board meeting
Meeting on 11 Nov 2019: quarterly results
Jul 2019
31 Jul · Board meeting
Meeting on 13 Aug 2019: quarterly results
Jun 2019
May 2019
30 May · Board meeting
20 May · Board meeting
Meeting on 10 Jun 2019: dividend and audited results
Feb 2019
1 Feb · Board meeting
Meeting on 11 Feb 2019: quarterly results
Dec 2018
Nov 2018
Oct 2018